|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8740 USD | -0.68% |
|
-0.68% | -1.13% |
| 07-01 | BioPharma Credit to be repaid following disposal by BioCryst | AN |
| 05-22 | BioPharma Credit Receives $83 Million from OptiNose Sale | MT |
| Capitalization | 987M 844M 786M 731M 1.35B 84.69B 1.5B 9.42B 3.6B 39.65B 3.7B 3.63B 145B | P/E ratio 2023 |
10.1x | P/E ratio 2024 | 8.84x |
|---|---|---|---|---|---|
| Enterprise value | 981M 839M 782M 727M 1.34B 84.21B 1.49B 9.37B 3.58B 39.43B 3.68B 3.6B 145B | EV / Sales 2023 |
7.07x | EV / Sales 2024 | 6.96x |
| Free-Float |
83.82% | Yield 2023 |
8.33% | Yield 2024 | 7.92% |
More valuation ratios
* Estimated data
More news
| BioPharma Credit : Half-year Report | 24/09/24 | PU |
| BioPharma Credit : Resolutions passed at AGM | 13/06/24 | PU |
| BioPharma Credit : Resolution passed at General Meeting | 28/12/23 | PU |
| BioPharma Credit : Change of AGM Venue | 19/06/20 | PU |
| BioPharma Credit : Notice of AGM | 29/05/20 | PU |
| 1 day | -0.68% | ||
| 1 week | -0.68% | ||
| Current month | -1.13% | ||
| 1 month | -1.58% | ||
| 3 months | +4.80% | ||
| 6 months | +2.10% | ||
| Current year | -1.13% |
| 1 week | 0.86 |  | 0.89 |
| 1 month | 0.86 | | 0.98 |
| Current year | 0.8 | | 0.98 |
| 1 year | 0.8 | | 0.98 |
| 3 years | 0.8 | | 0.98 |
| 5 years | 0.8 | | 1.05 |
| 10 years | 0.7 | | 1.13 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Investment Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Duncan Budge
BRD | Director/Board Member | 69 | - |
| Director/Board Member | 65 | 31/10/2016 | |
Harry Hyman
CHM | Chairman | 68 | 15/09/2020 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.68% | -0.68% | +0.46% | -7.42% | 987M | ||
| +1.06% | +0.59% | +37.43% | +89.53% | 11.93B | ||
| -0.24% | +0.43% | -1.28% | +67.66% | 10.09B | ||
| -0.05% | -0.68% | +0.53% | -8.13% | 7.18B | ||
| +2.78% | +3.27% | +20.58% | +99.23% | 6.98B | ||
| +0.88% | +1.82% | +7.29% | +6.82% | 6.1B | ||
| +2.09% | +2.46% | +33.79% | +102.86% | 6.04B | ||
| +0.49% | -6.45% | -18.09% | +69.75% | 4.71B | ||
| -0.44% | +1.33% | +1.93% | +3.16% | 4.26B | ||
| -0.35% | +1.76% | -4.47% | -6.56% | 4.02B | ||
| Average | +0.15% | -0.36% | +7.82% | +41.69% | 6.23B | |
| Weighted average by Cap. | +0.19% | -0.08% | +11.80% | +53.87% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 136M 116M 108M 101M 186M 11.65B 206M 1.3B 495M 5.45B 509M 499M 20B | 150M 128M 119M 111M 205M 12.87B 228M 1.43B 547M 6.03B 563M 551M 22.11B |
| Net income | 108M 92.74M 86.38M 80.34M 148M 9.31B 165M 1.04B 396M 4.36B 407M 398M 15.98B | 122M 104M 97.31M 90.51M 167M 10.48B 186M 1.17B 446M 4.91B 458M 449M 18B |
| Net Debt | -135M -115M -108M -100M -185M -11.59B -205M -1.29B -493M -5.43B -507M -496M -19.9B | -5.62M -4.81M -4.48M -4.16M -7.69M -482M -8.55M -53.64M -20.51M -226M -21.08M -20.64M -828M |
More financial data
* Estimated data
Employees
-
Sector
Closed End Funds
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/07/25 | 0.8740 $ | -0.68% | 1,890,282 |
| 10/07/25 | 0.8800 $ | 0.00% | 1,638,582 |
| 09/07/25 | 0.8800 $ | 0.00% | 715,330 |
| 08/07/25 | 0.8800 $ | 0.00% | 391,608 |
| 07/07/25 | 0.8800 $ | 0.00% | 704,819 |
Delayed Quote London S.E., July 11, 2025 at 04:35 pm
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
0.8740
Average target price
-
Annual profits - Rate of surprise
- Stock Market
- Equities
- BPCP Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition